R3i-Stiftung - Residual Risk Reduction Initiative
ExistingCH27070030171
Die Stiftung bezweckt, zur Förderung des Allgemeinwohls weltweit Anstrengungen zu unternehmen, das trotz kunstgerechter Behandlung verbleibende Restrisiko makro- und mikrovaskulärer Vorfälle bei Herz-Kreislauf- und Diabetes-Patienten zu reduzieren.
Basic Information
| Legal Form | Foundation |
|---|---|
| Summary | The company's purpose is to reduce the risk of macro- and microvascular events in patients with heart, circulatory, and diabetes conditions. This suggests that the company may be involved in manufacturing medical devices or providing healthcare services. |
Address
| Company Name | R3i-Stiftung - Residual Risk Reduction Initiative |
|---|---|
| Postal Code | 4052 |
| City | Basel |
| Canton | Basel-Stadt |
| Country | Switzerland |
Business Activities
Human Health and Social Work ActivitiesManufacturing
Contact Information
| Website | https://r3i.org |
|---|
Additional Information
| Registered | 20.9.2025 |
|---|---|
| Commercial Register Entry | CH27070030171 |
| Last Updated | 13.12.2025 |